Early-stage B2B tech startups get a boost from Bluelion

With about 60% of alumni receiving funding within 6 months of program completion, the Bluelion Accelerator Program has established itself as a stepping-stone for tech B2B businesses to fast track their development. The 10-week accelerator program provides early-stage companies with the platform to grow their businesses by exploring fundamental topics, from team setup to fundraising strategies in the pre-seed phase, and get access to a network of industry experts and entrepreneurs, who share their personal success recipes.

The new cohort comprises the following startups:

Atenia AI – is developing a Digital Infrastructure engineer that automates the end-to-end workflow of software infrastructure management.

Sign.mt – is an open-source application designed to facilitate real-time, bidirectional translation between spoken and signed languages.

DATABIOMIX – leverages a one-stop shop for fast and high-resolution microbiota biomarker discovery, microbial screenings, and microbiome-based diagnostic assay development.

Uthereal.ai – develops an AI platform that transforms expert knowledge into intelligent systems capable of delivering personalized representations of individuals and organizations.

Skriba – offers an AI-powered collaborative tool designed to create qualified interim and employment references in compliance with Swiss standards, enabling businesses to generate semantically optimized texts up to ten times faster.

InsightSphere – empowers employees to present and sell with confidence. They offer VR presentation skills training and a personalized sales simulation.

UpGrid’s platform empowers energy communities to co-own, share, and store clean energy. They are building the digital backbone of tomorrow’s grid: local, connected, and smart.

PermeaSense – is a plug-and-play microfluidic platform that maps real-time drug penetration into biofilms, accelerating the development of effective anti-biofilm treatments.

Winduction – revolutionizes EV charging solutions by developing an efficient and safe wireless power transfer technology that integrates seamlessly into the existing road infrastructure.

Rekonas – is developing a mask-free home therapy that treats sleep apnea without uncomfortable face masks. The company saves costs by phenotyping patients first, and identifying ideal candidates before treatment begins.

(RAN)